The page is the record's research on the issuer — no analyst, no rating, no view. # Vir Biotechnology, Inc. (NASDAQ: VIR) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Vir Biotechnology, Inc., listed on NASDAQ under ticker VIR, with ISIN US92764N1028. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 110 filings across 62 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 4 days. The latest filing is dated 2026-11-06, a regulatory_filing, and is 2 days before the record date. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days. By type, the window holds 44 regulatory filings, 41 directors' dealings, 8 results, 7 director changes, 6 corporate news, 2 prospectuses and 2 AGM/EGM filings. ## Auditor The auditor of record is Ernst & Young LLP, located in San Mateo, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is not set: the issuer is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001706431.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/VIR (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1706431/000162828026010749/vir-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/VIR (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/VIR · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp